- Home
- EHGO vs VIGL Comparison
EHGO vs VIGL Comparison
Compare EHGO & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHGO
- VIGL
- Stock Information
- Founded
- EHGO 2015
- VIGL 2020
- Country
- EHGO China
- VIGL United States
- Employees
- EHGO N/A
- VIGL N/A
- Industry
- EHGO
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- EHGO
- VIGL Health Care
- Exchange
- EHGO NYSE
- VIGL Nasdaq
- Market Cap
- EHGO N/A
- VIGL 134.9M
- IPO Year
- EHGO 2024
- VIGL 2022
- Fundamental
- Price
- EHGO $0.86
- VIGL $7.97
- Analyst Decision
- EHGO
- VIGL Buy
- Analyst Count
- EHGO 0
- VIGL 7
- Target Price
- EHGO N/A
- VIGL $8.00
- AVG Volume (30 Days)
- EHGO 1.3M
- VIGL 1.6M
- Earning Date
- EHGO 07-15-2025
- VIGL 08-12-2025
- Dividend Yield
- EHGO N/A
- VIGL N/A
- EPS Growth
- EHGO N/A
- VIGL N/A
- EPS
- EHGO N/A
- VIGL N/A
- Revenue
- EHGO $15,393,105.00
- VIGL N/A
- Revenue This Year
- EHGO N/A
- VIGL N/A
- Revenue Next Year
- EHGO N/A
- VIGL N/A
- P/E Ratio
- EHGO N/A
- VIGL N/A
- Revenue Growth
- EHGO N/A
- VIGL N/A
- 52 Week Low
- EHGO $0.74
- VIGL $1.31
- 52 Week High
- EHGO $5.50
- VIGL $7.97
- Technical
- Relative Strength Index (RSI)
- EHGO N/A
- VIGL 88.65
- Support Level
- EHGO N/A
- VIGL $7.86
- Resistance Level
- EHGO N/A
- VIGL $7.96
- Average True Range (ATR)
- EHGO 0.00
- VIGL 0.03
- MACD
- EHGO 0.00
- VIGL -0.19
- Stochastic Oscillator
- EHGO 0.00
- VIGL 100.00
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.